system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Aged, Blood Loss, Surgical, Blood Transfusion, Autologous, Carcinoma, Transitional Cell, Cystectomy, Disease-Free Survival, Female, Follow-Up Studies, Humans, Intraoperative Care, Male, Middle Aged, Probability, Reference Values, Retrospective Studies, Risk Assessment, Salvage Therapy, Survival Analysis, Time Factors, Treatment Outcome, Urinary Bladder Neoplasms.
user
Does intraoperative cell salvage during radical cystectomy affect long-term survival? Context: To evaluate the risk of long-term recurrence for patients who received cell-salvaged blood during radical cystectomy (RC). We retrospectively analyzed an RC database and compared those who did and did not receive cell-salvaged blood according to baseline parameters, pathologic outcomes, and recurrence. A total of 378 patients underwent RC between 1992 and 2005 by one surgeon. Of these, 65 (17.2%) received cell-salvaged blood and 313 (82.8%) did not. The two groups had similar baseline characteristics. There were no differences between the two groups when compared by pathologic stage. The median follow-up for patients who did and did not receive cell-salvaged blood was 19.1 and 20.7 months, respectively (P = 0.464). The 3-year disease-specific survival rate for the two groups was 72.2% and 73.0%, respectively (P = 0.90).
assistant
Intraoperative cell salvage is a safe blood management strategy for patients undergoing RC. There is no increased risk of metastatic disease or death for those who receive cell-salvaged blood. Concerns about spreading tumors cells by IOCS during RC would seem unwarranted. However, only a prospective, multicenter, randomized trial would provide the most valid assessment of the safety of IOCS. Final Decision: no